PTC Therapeutics (PTCT)

63.99 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (3/3/21 *Est.)
- M&A (Rumor)
- Conference (12/1/2020)

Latest Headlines

PTC Therapeutics (PTCT) Reports Initiation of Global Phase 3 Clinical Trial to Evaluate Vatiquinone in Friedreich Ataxia November 30, 2020 8:09 AM - StreetInsider PTC Therapeutics Announces Initiation of Global Phase 3 Clinical Trial to Evaluate Vatiquinone in Friedreich Ataxia November 30, 2020 8:00 AM - PR NewsWire UPDATE: RBC Capital Downgrades PTC Therapeutics (PTCT) to Underperform November 30, 2020 5:12 AM - StreetInsider PTC Therapeutics to Present at the Evercore ISI 3rd Annual HealthCONx Conference November 19, 2020 8:00 AM - PR NewsWire PTC Therapeutics (PTCT) Granted Key Regulatory Designations for PTC596 to Advance Treatment of Two Rare Oncology Indications November 18, 2020 8:02 AM - StreetInsider PTC Therapeutics Announces Key Regulatory Designations for PTC596 to Advance Treatment of Two Rare Oncology Indications November 18, 2020 8:00 AM - PR NewsWire PTC Therapeutics (PTCT) Announces that PTC518 Has Entered into a Phase 1 Clinical Trial for the Huntington's Disease Program November 17, 2020 8:04 AM - StreetInsider PTC Therapeutics Announces that PTC518 Has Entered into a Phase 1 Clinical Trial for the Huntington's Disease Program November 17, 2020 8:00 AM - PR NewsWire PTC Therapeutics Highlights Data on High Disease Burden and Value of Treatment Across Two Rare Diseases November 16, 2020 8:00 AM - PR NewsWire Form 4 PTC THERAPEUTICS, INC. For: Nov 04 Filed by: Peltz Stuart Walter November 6, 2020 4:41 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Nov 04 Filed by: Utter Christine Marie November 6, 2020 4:36 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Nov 04 Filed by: Jacobson Allan Steven November 6, 2020 4:31 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Nov 04 Filed by: Almstead Neil Gregory November 6, 2020 4:27 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Nov 03 Filed by: Pauwels Eric November 5, 2020 4:26 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Nov 02 Filed by: Peltz Stuart Walter November 3, 2020 7:53 PM - SEC Filing PTC Therapeutics (PTCT) PT Raised to $90 at Truist Securities November 2, 2020 7:48 AM - StreetInsider Citi Downgrades PTC Therapeutics (PTCT) to Neutral October 30, 2020 10:15 AM - StreetInsider PTC Therapeutics (PTCT) PT Raised to $90 at Truist Securities October 30, 2020 9:31 AM - StreetInsider PTC Therapeutics (PTCT) PT Raised to $53 at Credit Suisse October 30, 2020 6:49 AM - StreetInsider PTC Therapeutics (PTCT) Misses Q3 EPS by 97c, Revenues Beat October 29, 2020 5:14 PM - StreetInsider Form 10-Q PTC THERAPEUTICS, INC. For: Sep 30 October 29, 2020 4:39 PM - SEC Filing Form 8-K PTC THERAPEUTICS, INC. For: Oct 29 October 29, 2020 4:07 PM - SEC Filing PTC Therapeutics Reports Third Quarter 2020 Financial Results and Provides a Corporate Update October 29, 2020 4:01 PM - PR NewsWire PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 28, 2020 4:30 PM - PR NewsWire PTC Therapeutics to Participate at Upcoming Virtual Investor Conferences October 28, 2020 8:00 AM - PR NewsWire UPDATE: PTC Therapeutics (PTCT) Initiated Neutral at UBS October 27, 2020 4:50 PM - StreetInsider PTC Therapeutics Announces Initiation of a Registration-Directed Clinical Trial to Evaluate Vatiquinone in Mitochondrial Epilepsy October 26, 2020 8:00 AM - PR NewsWire PTC Therapeutics and AADC Family Network Announce First-Ever AADC Deficiency Awareness Day in Massachusetts October 22, 2020 8:00 AM - PR NewsWire PTC Therapeutics (PTCT) Says Evrysdi Continues to Make Global Progress for the Treatment of Spinal Muscular Atrophy October 21, 2020 8:34 AM - StreetInsider Evrysdi™ (risdiplam) Continues to Make Global Progress for the Treatment of Spinal Muscular Atrophy October 21, 2020 8:33 AM - PR NewsWire Form 4 PTC THERAPEUTICS, INC. For: Oct 16 Filed by: Jacobson Allan Steven October 20, 2020 4:36 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Oct 16 Filed by: SOUTHWELL DAVID P October 20, 2020 4:34 PM - SEC Filing PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2020 Financial Results October 15, 2020 8:00 AM - PR NewsWire Form 4 PTC THERAPEUTICS, INC. For: Oct 07 Filed by: Peltz Stuart Walter October 9, 2020 4:21 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Oct 05 Filed by: Peltz Stuart Walter October 7, 2020 9:02 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Oct 05 Filed by: Utter Christine Marie October 7, 2020 9:00 PM - SEC Filing UPDATE: JPMorgan Upgrades PTC Therapeutics (PTCT) to Overweight October 7, 2020 4:07 AM - StreetInsider PTC Therapeutics (PTCT) Two-Year Data of Evrysdi in Infants with Spinal Muscular Atrophy Demonstrate Continued Improvement of Developmental Milestones September 28, 2020 6:27 AM - StreetInsider Two-Year Data of Evrysdi™ (risdiplam) in Infants with Spinal Muscular Atrophy Demonstrate Continued Improvement of Developmental Milestones September 28, 2020 1:00 AM - PR NewsWire PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 25, 2020 4:30 PM - PR NewsWire PTC Therapeutics to Present at the Jefferies Virtual Gene Therapy/Editing Summit September 24, 2020 8:00 AM - PR NewsWire Form CT ORDER PTC THERAPEUTICS, INC. September 17, 2020 2:10 PM - SEC Filing PTC Therapeutics (PTCT) PT Lowered to $45 at RBC Capital September 15, 2020 6:19 AM - StreetInsider PTC Therapeutics Launches PTC PINPOINT - A Genetic Testing Program for Individuals Suspected of Having Neurotransmitter Disorders September 9, 2020 8:00 AM - PR NewsWire PTC Therapeutics' 2020 STRIVE Awards for Duchenne Muscular Dystrophy Recognize Four Patient Advocacy Organizations September 8, 2020 8:00 AM - PR NewsWire PTC Therapeutics to Present at the Cantor Virtual Global Healthcare Conference September 3, 2020 8:00 AM - PR NewsWire Full Article List